SEC Filings

 
SEC Filings
Date Filing Description View
Oct 5, 2004 3 baker julian HTML PDF XLS
30.5 KB
Add to Briefcase
Oct 5, 2004 424B4 prospectus filed pursuant to rule 424 HTML PDF XLS
1.1 MB
Add to Briefcase
Oct 5, 2004 S-1MEF registration statement HTML PDF XLS
46.4 KB
Add to Briefcase
Oct 4, 2004 3 glaxosmithkline plc HTML PDF XLS
31.9 KB
Add to Briefcase
Oct 4, 2004 3 kitt michael HTML PDF XLS
34.0 KB
Add to Briefcase
Oct 4, 2004 3 vagelos p roy HTML PDF XLS
31.9 KB
Add to Briefcase
Oct 4, 2004 3 drazan jeffrey m HTML PDF XLS
31.0 KB
Add to Briefcase
Oct 4, 2004 3 levine arnold j HTML PDF XLS
29.3 KB
Add to Briefcase
Oct 4, 2004 3 loewenthal ronn HTML PDF XLS
30.7 KB
Add to Briefcase
Oct 4, 2004 3 mullen michael HTML PDF XLS
30.6 KB
Add to Briefcase
FirstPrevious
...
119
NextLast
= add PDF file to Briefcase

Innoviva NASDAQ: INVA

$16.10 0.11 (0.68%) 02/23/18 4:00 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.